Elsevier Health to showcase the impact of AI and digital health transformation in India at the 2024 Global Digital Health Summit

Elsevier, a global leader in medical information and data analytics, announced today its participation in the Global Digital Health Summit 新しいタブ／ウィンドウで開く (GDHS-24) taking place in Mumbai, India on October 4-5. The premier event convenes thousands of physicians, healthcare leaders, policymakers and digital health companies from around the world and provides a platform to showcase cutting-edge technologies and facilitate discussions on the widespread deployment of digital technologies, including AI.

Jan Herzhoff, PhD, President, Elsevier Health said: “As a company with a strong presence in India, we are excited to partner with the Global Digital Health Summit to highlight the importance of AI and digital health solutions in the transformation of the healthcare system in the country. We also look forward to gathering with providers and partners and exchanging ideas on how we can all collaborate more effectively across the public and private sector to drive positive change that will benefit all patients.”

As a leading global provider of clinical solutions, Elsevier has been delivering trusted research content, localized digital solutions and insightful analytics in India since 1996. In the healthcare sector, Elsevier’s solutions are used by clinicians across India in delivering quality patient care and enhancing health outcomes.

Some of the key products include ClinicalKey, a leading clinical decision support and reference tool for hospital systems and medical schools that supports point of care and deep reference needs, and the newly launched ClinicalKey AI, which offers a conversational search interface with advanced generative AI to help physicians quickly find accurate and succinct clinical information based on one of the world’s largest and most trusted bodies of medical information available anywhere.

The Indian healthcare system is a diverse and complex network of public and private sectors that provide a wide range of medical services to the world’s largest population of 1.4 billion people. Despite undergoing significant systemic changes in recent years, the system continues to face challenges including inadequate infrastructure, a shortage of healthcare professionals, and urban-rural disparities throughout the country. These challenges are further intensified by the changing disease profile of India with non-communicable diseases (NCDs) like diabetes and hypertension.

One of the largest hurdles that India faces with its vast population is the marked disparity in the quality and accessibility of healthcare services between urban and rural areas. To help address this disparity, Elsevier is part of Digital Innovations & Interventions for Sustainable HealthTech Action (DIISHA), a strategic Public Private Partnership (PPP) pilot to empower and digitally upskill frontline healthcare workers like Accredited Social Heath Activists (ASHA) workers in building a sustainable rural health delivery model and revolutionizing last mile delivery in India. As part of this pilot, Elsevier Health will support the training of thousands of frontline healthcare workers across the country and the deployment of the expert led AI solution ClinicalPath Primary Care India to assist in the screening and assessment of patients in rural areas.

Mr. Herzhoff added, “We are proud to be a key partner in this national pilot and are committed to working alongside state governments in addressing health equity and improving access to quality care through our innovative suite of solutions now and in the future.”

About Elsevier Health

For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence-based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.

Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide. We bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.

エルゼビアについて

エルゼビアは情報分析を専門としたグローバル企業として、研究者や医療専門家の方々を支援し、社会にとっての利益最大化に向けて、科学や医療の進展を支えています。これは、信頼できるエビデンスによるコンテンツと高度なAI対応によるデジタル技術に基づく革新的なソリューションにより、知見の集積や重要な意思決定を支援することで実現されています。

エルゼビアは、全世界で9,700人の従業員（うち技術者2,300人以上）を抱え、140年以上にわたって、研究者、図書館員、アカデミックリーダー、資金提供者、政府、研究開発集約型企業、医師、看護師、将来の医療専門家、教育者など研究・医療分野におけるパートナーの重要な活動を支援してきました。エルゼビアが刊行する3,000誌以上の科学ジャーナルと代表的な参考書には、The Lancet 新しいタブ／ウィンドウで開く、Cell Press 新しいタブ／ウィンドウで開くおよびGray’s Anatomyなどをはじめとする、各分野を代表する主要なタイトルが含まれています。 エルゼビア・ファンデーション 新しいタブ／ウィンドウで開くとの活動を通し、私たちがサービスを提供する地域社会と連携して、開発途上国を含む世界中の医学、研究、医療分野における、インクルージョン＆ダイバーシティ（I&D）の改善に努めています。

エルゼビアは、専門家および企業向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Group 新しいタブ／ウィンドウで開くの一事業を担っています。エルゼビアの事業内容、デジタルソリューション、コンテンツなどの詳細については、www.elsevier.comをご覧ください。